News Express
-
Science News: Impaired B Cell Expression of the Inhibitory Fcγ Receptor IIB in Myasthenia Gravis
August 03, 2023
In this study, the authors report that FcγRIIB expression levels are substantially reduced in B lineage cells derived from immunotherapy-naïve patients with acetylcholine receptor (AChR) antibody-positive (Ab+) early-onset MG. In contrast, genetic variants associated with impaired FcγRIIB expression are not enriched in MG, indicating posttranscriptional dysregulation. The authors suggest that FcγRIIB-targeting therapies could have therapeutic benefits in AChR-Ab+ MG.
-
Teresa Spiegelberg, CNCT, R.NCS.T., R.EEG.T, BS, Receives Inaugural Outstanding Service Award
August 02, 2023
The AANEM Outstanding Service Award recognizes non physicians for their contributions to the fields of NM and EDX medicine. Teresa Spiegelberg, CNCT, R.NCS.T., R.EEG.T, BS, has been awarded the inaugural Outstanding Service Award for her dedicated service to patients, medical education, and AANEM.
-
Colin K. Franz, MD, PhD, Receives One of AANEM’s 2023 Scientific Impact Awards
August 02, 2023
Colin K. Franz, MD, PhD, has been awarded one of AANEM’s 2023 Scientific Impact Awards for his significant contribution as senior author of The Distribution of Acquired Peripheral Nerve Injuries Associated With Severe COVID-19 Implicate a Mechanism of Entrapment Neuropathy: A Multicenter Case Series and Clinical Feasibility Study of a Wearable, Wireless Pressure Sensor, published in the October 2022 issue of Journal of NeuroEngineering and Rehabilitation.
-
Elie Naddaf, MD, Receives One of AANEM’s 2023 Scientific Impact Awards
August 02, 2023
Elie Naddaf, MD, has been awarded one of AANEM’s 2023 Scientific Impact Awards for his significant contribution as senior author of Survival and Associated Comorbidities in Inclusion Body Myositis, which appeared in the September 2021 issue of Rheumatology. Co-authors include Shahar Shelly, Jay Mandrekar, Alanna M. Chamberlain, E. Matthew Hoffman, Floranne C. Ernst, and Teerin Liewluck.
-
Monika Krzesniak-Swinarska, MD, Receives AANEM’s 2023 Ernest Johnson Outstanding Educator Award
August 02, 2023
Monika Krzesniak-Swinarska, MD, has been awarded AANEM’s 2023 Ernest Johnson Outstanding Educator Award for her unwavering dedication to education in the fields of NM and EDX medicine.
-
Amanda C. Peltier, MD, MS, Receives AANEM’s 2023 Jun Kimura Outstanding Educator Award
August 02, 2023
Amanda C. Peltier, MD, MS, has been awarded AANEM’s 2023 Jun Kimura Outstanding Educator Award for her numerous contributions and dedication to advancing medical education in the fields of NM and EDX medicine.
-
David R. Cornblath, MD, Receives AANEM’s 2023 Distinguished Researcher Award
August 02, 2023
David R. Cornblath, MD, has been awarded AANEM’s 2023 Distinguished Researcher Award for his contributions to the study of peripheral neuropathies and his extensive research in the fields of NM and EDX medicine. This award honors AANEM members who have made a significant impact on clinical neurophysiological, NM medicine, or MSK research.
-
Bassam A. Bassam, MD, Receives AANEM’s 2023 Distinguished Physician Award
August 02, 2023
Bassam A. Bassam, MD, has been awarded AANEM’s 2023 Distinguished Physician Award for his exceptional contributions to patient care, research, and education in the fields of NM and EDX medicine. This prestigious award honors AANEM members who have provided distinguished service as a clinician and/or educator and been an active supporter of AANEM activities.
-
John C. Kincaid, MD, Receives AANEM's Prestigious 2023 Lifetime Achievement Award
August 02, 2023
John C. Kincaid, MD, has been awarded AANEM’s 2023 Lifetime Achievement Award for his lifelong dedication to research, patient care, advocacy, and education. This award is the highest honor bestowed by AANEM, and is given to members who are recognized as major contributors in the fields of NM and EDX medicine.
-
Trainee Talk: Top 3 Training Program Partnership (TPP) Benefits for Residents & Fellows
July 24, 2023
Top 3 Training Program Partnership (TPP) Benefits for Residents & Fellows
-
Science News: Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis
July 24, 2023
This prospective study investigated the safety profile of mRNA-1273 vaccine and its ability to induce humoral and cellular responses in patients with mysthenia gravis (MG).
-
Science News: Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis
July 07, 2023
In this study, the authors conducted a population-based study on inclusion body myositis (IBM) with the primary aims to define the disease prevalence, survival rate, and incidence, and to investigate the symptom profiles associated with disease duration and sex over a 33-year period. A total of 128 patients fulfilled the clinicopathological definition of IBM.
-
Be a Voice for Young Physicians: Apply Now for the AANEM Young Leadership Council
July 07, 2023
Applications are now open for the AANEM Young Leadership Council! This group offers an excellent opportunity for medical students, residents, and fellows to get involved in a professional association; gain valuable leadership experience; connect with leaders in NM, MSK, US, and EDX medicine; and make a meaningful impact.
-
AANEM Attends AMA House of Delegates Meeting
July 06, 2023
AANEM Attended the AMA House of Delegates Meeting in Chicago, Illinois for it's annual meeting in mid-June. The meeting covered a wide range of important, timely topics currently affecting health care in the U.S.
-
Trainee Talk: Young Leadership Council 2023 Emerging Leaders Forum
June 26, 2023
Our inaugural Young Leadership Council was established at the 2022 AANEM Annual Meeting and is made up of 12 residents and fellows from programs across the country. Our purpose is to represent the trainee voice within the AANEM and spearhead initiatives to bolster educational, mentorship, networking, and leadership opportunities. Our council convened at AANEM spring meeting May 6, 2023, in Chicago to work towards these goals and to participate in AANEM-sponsored career development and leadership training.
-
Science News: Treatment for Spinal Muscular Atrophy Using Onasemnogene Abeparvovec
June 26, 2023
The article summarizes the development, safety, and efficacy of intravenously administered drugs using the Adeno-associated virus vector for SMA type 1 and intrathecal administration for SMA type 2.
-
Science News: Diagnostic Performance of Preoperative Ultrasound for Traumatic Brachial Plexus Root Injury: A Comparison Study With an Electrophysiology Study
June 09, 2023
This retrospective study aimed to investigate the diagnostic performance of preoperative ultrasound (US) compared with electrophysiology study (EPS) in the assessment of traumatic brachial plexus (BP) root injury. Patients with suspected traumatic BP root injury who underwent preoperative US and EPS examination were included in the analysis. Each BP root was assessed via US and EPS as either completely or incompletely injured.
-
Submit an Abstract for the Myasthenia Gravis Foundation of America’s 2023 Scientific Session
June 02, 2023
The abstract submission window for the 2023 Scientific Session of the Myasthenia Gravis Foundation of America, Inc. (MGFA), is officially open. This year’s deadline is June 18, 2023.
-
Science News: Physical Activity in People With Motor Neuron Disease: Validity of the Physical Activity Scale for the Elderly as a Measuring Tool
June 02, 2023
This prospective, observational study investigated the physical activity scale for the elderly (PASE) as a tool to measure physical activity in patients with motor neuron disease (MND). The PASE is a brief questionnaire that assesses the type, frequency, duration, and intensity of the physical activities chosen by the patient over the previous week to assign a score ranging from 0-793, with higher scores indicating greater physical activity.
-
Science News: MRI Clustering Reveals Three ALS Subtypes With Unique Neurodegeneration Patterns
May 14, 2023
The purpose of this study was to identify subtypes of amyotrophic lateral sclerosis (ALS) by comparing patterns of neurodegeneration using brain magnetic resonance imaging (MRI) and explore their phenotypes.